Erasca, Inc. (ERAS)
14.02
+0.66
(+4.90%)
USD |
NASDAQ |
Jun 11, 16:00
14.02
0.00 (0.00%)
After-Hours: 18:46
Erasca Total Liabilities (Quarterly) : 67.71M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 67.71M |
| December 31, 2025 | 82.28M |
| September 30, 2025 | 72.52M |
| June 30, 2025 | 73.13M |
| March 31, 2025 | 71.74M |
| December 31, 2024 | 79.03M |
| September 30, 2024 | 78.85M |
| June 30, 2024 | 74.66M |
| March 31, 2024 | 81.61M |
| December 31, 2023 | 78.61M |
| September 30, 2023 | 80.43M |
| Date | Value |
|---|---|
| June 30, 2023 | 77.96M |
| March 31, 2023 | 81.09M |
| December 31, 2022 | 103.06M |
| September 30, 2022 | 81.11M |
| June 30, 2022 | 49.76M |
| March 31, 2022 | 50.81M |
| December 31, 2021 | 44.89M |
| September 30, 2021 | 38.96M |
| June 30, 2021 | 19.58M |
| March 31, 2021 | 13.09M |
| December 31, 2020 | 17.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 753.82M |
| Tango Therapeutics, Inc. | 44.29M |
| Kymera Therapeutics, Inc. | 129.38M |
| Bridgebio Oncology Therapeutics, Inc. | 45.37M |
| ImmunityBio, Inc. | 1.516B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 461.23M |
| Shareholders Equity (Quarterly) | 393.53M |
| Debt to Equity Ratio | 0.1168 |
| Current Ratio | 9.518 |
| Net Debt Paydown Yield | 0.02% |